Influenza

On Dec. 14, the CDC issued an urgent warning calling for health care providers to increase vaccination coverage for COVID-19, influenza and respiratory syncytial virus.

Wastewater surveillance can effectively detect upticks in viral respiratory infections, which could help identify outbreaks, another study has shown.

A recombinant influenza vaccine offered additional protection against PCR-confirmed influenza and community-acquired pneumonia hospitalization among adults aged 50 to 64 years compared with a standard-dose vaccine, study results showed.

Influenza vaccine efficacy during the 2022-2023 influenza season was “moderate” but still prevented many health care encounters and hospitalizations among adult patients, researchers determined.

The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.

Annual influenza vaccinations are important for pregnant individuals due to higher risks for complications for the mother, fetus and infant, according to an ACOG committee statement.

It's that time of year again, everyone rolling up their sleeves to get a flu shot. This episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!

Use of antivirals to treat influenza in children remains low despite their wide availability and guidelines recommending their use, according to a study published in Pediatrics.

When given together, Pfizer’s respiratory syncytial virus vaccine and the seasonal influenza vaccine generated robust immune responses and were well tolerated among older adults when coadministered, data from a recent study showed.

Influenza vaccination was linked to significant decreased risks for major cardiovascular events and death, according to a study published in Scientific Reports.